Who Paid My Doc
Joseph Domachowske
Pediatric Infectious Diseases Syracuse, NY Medical Doctor
NPI 1720007651 CMS profile 33124
750 E Adams St, Syracuse, NY 13210
General payments
$470,276
Research payments
$3,200
Ownership & investment interest
$0
Research they led as principal investigator
$4,127,329
Through program year 2025, Joseph Domachowske of Syracuse, NY is reported in the CMS Open Payments database as having received $470,276 across 336 general payments and $3,200 in research payments paid to them. Separately, studies naming them as principal investigator received $4,127,329 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Pediatric Infectious Diseases profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $142,525 | 78 | |
| 2024 | General | $91,516 | 46 | |
| 2023 | General | $88,540 | 63 | |
| 2022 | General | $80,612 | 74 | |
| 2022 | Research | $3,200 | 1 | |
| 2021 | General | $47,239 | 39 | |
| 2020 | General | $2,315 | 3 | |
| 2019 | General | $17,530 | 33 |
Beside peers
- Joseph Domachowske
- Pediatric Infectious Diseases median
- Middle half of Pediatric Infectious Diseases
- National median
In program year 2025, general payments to Joseph Domachowske were reported at $142,525. Among 311 Pediatric Infectious Diseases profiles paid that year, the median was $126 and the middle half received between $41 and $2,094.
Show as a table
| Year | Joseph Domachowske | Pediatric Infectious Diseases median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $17,530 | $175 | $34–$2,175 | $163 |
| 2020 | $2,315 | $521 | $34–$6,009 | $114 |
| 2021 | $47,239 | $1,077 | $39–$4,557 | $132 |
| 2022 | $80,612 | $232 | $53–$6,196 | $149 |
| 2023 | $88,540 | $140 | $52–$4,662 | $160 |
| 2024 | $91,516 | $198 | $52–$3,860 | $164 |
| 2025 | $142,525 | $126 | $41–$2,094 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
337 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Infectious Diseases in New York
Jana Shaw
Pediatric Infectious Diseases · Watertown, NY
Philip Larussa
Pediatric Infectious Diseases · New York, NY
Lisa Saiman
Pediatric Infectious Diseases · New York, NY
Leonard Krilov
Pediatric Infectious Diseases · Mineola, NY
Brenda Tesini
Pediatric Infectious Diseases · Rochester, NY
Margaret Hammerschlag
Pediatric Infectious Diseases · Brooklyn, NY
Related records
Pediatric Infectious Diseases in New York
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Infectious Diseases
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.